Connect with us

Hi, what are you looking for?

Right Decision NowRight Decision Now

Business

Cannumo secures record €1m Shark Tank investment to accelerate UK expansion

Cannumo, the Lithuanian wellness start-up behind the live-bacteria drink Goodie, has secured a record-breaking €1 million investment on Shark Tank Lithuania — the largest deal ever reported on any European business reality show.

Cannumo, the Lithuanian wellness start-up behind the live-bacteria drink Goodie, has secured a record-breaking €1 million investment on Shark Tank Lithuania — the largest deal ever reported on any European business reality show.

The investment came from entrepreneur Tadas Burgaila, co-founder of the Kilo Group and founder of accelerator Lost Astronaut. Burgaila committed €600,000 for a 20% equity stake, alongside €400,000 in loan financing, marking a milestone for both Lithuania’s start-up sector and the broader European TV format.

Cannumo develops live-bacteria wellness products aimed at the fast-growing functional beverage market. On the programme, the founders showcased Goodie, a fermented drink containing 96 live bacterial cultures, produced in Lithuania and positioned as a healthier, alcohol-free alternative for long-term gut support.

Co-founders Mykolas Karpičius and Dominykas Ježerys told investors they have already poured around €500,000 of their own capital into launching Goodie and scaling production.

Following Burgaila’s backing, Cannumo is preparing an intensive 90-day push into the UK — one of the world’s largest e-commerce markets for health and wellness products. Goodie is already stocked in several European countries, and Cannumo is also developing a new gut-health product for the US.

“This investment and partnership with Tadas are hugely important for us,” Karpičius said. “We share the same vision, and his experience is exactly what Cannumo and Goodie need as we expand internationally.”

Ježerys added that the company’s rapid domestic success demonstrated global appetite for healthier beverage alternatives. “Our community in Lithuania has shown that people everywhere want meaningful, health-focused brands. Now we’re ready to meet that demand globally.”

Explaining his investment, Burgaila said the founders displayed a rare strength in commercial execution. “Most Lithuanian businesses lack this — they know how to sell,” he said. “The probiotics market is huge and interest is only growing. Listening to Cannumo’s story, I realised these are people who want to grow rapidly and reach new heights.”

He set an ambitious goal for the company: achieving a €30 million valuation within the next 12 months.

Shark Tank Lithuania producer Laurynas Šeškus said the deal sets a new benchmark: “Based on available data, this is the largest investment across all European business reality shows. It shows Lithuanian founders are building products ready to compete globally.”

Founded just three years ago, Cannumo has become one of the Baltic region’s fastest-growing wellness brands. Its live-bacteria beverages have earned international recognition, including: Best New Product Launch – NielsenIQ Awards, Best New Health Product – NOPEX 2024 and the Taste Innovation Award – Anuga 2025.

Read more:
Cannumo secures record €1m Shark Tank investment to accelerate UK expansion

    You May Also Like

    Stocks

    The market sell-off continued in earnest after a brief respite on Friday. Uncertainty of geopolitical tensions and tariff talk has spooked the market and...

    World News

    KANANASKIS, Alberta – Ukrainian President Volodymyr Zelenskiy leaves the Group of Seven summit on Tuesday with new aid from host Canada for its war against Russia...

    Stocks

    In this video, Dave analyzes the bearish rotation in his Market Trend Model, highlighting the S&P 500 breakdown below the 200-day moving average and...

    Stocks

    Sector Shake-Up: Defensive Moves and Tech’s Tumble Last week’s market volatility stirred up the sector rankings, with 6 out of 11 sectors changing positions....

    Disclaimer: rightdecisionnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 rightdecisionnow.com | All Rights Reserved